EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2 ‐low and HER2 ‐zero breast cancer among Chinese females

Lu Zheng, Yunmeng Zhang, Zhipeng Wang, Huan Wang, Chunfang Hao, Chenyang Li, Yanrui Zhao, Zhangyan Lyu, Fangfang Song, Kexin Chen, Yubei Huang, Fengju Song iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6129 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Lu Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Tianjin's Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Genetic Predisposition to Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese National Key Research and Development Project, National Natural Science Foundation of China, Tianjin Health Committee Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Traditional human epidermal growth factor receptor 2 (HER2)‐negative breast cancer (BC) is recommended to be divided into HER2‐low and HER2‐zero subtypes due to different prognosis. However, few studies investigated their differences in clinical characteristics and prognosis among Chinese HER2‐negative BC and their stratified differences by hormone receptor (HR), while fewer studies investigated their differences in epidemiological factors and genetic susceptibility.

Methods

A total of 11,911 HER2‐negative BC were included to compare the clinical characteristics and prognosis between HER2‐zero and HER2‐low BC, and 4227 of the 11,911 HER2‐negative BC were further compared to 5653 controls to investigate subtype‐specific epidemiological factors and single nucleotide polymorphisms(SNPs).

Results

Overall, 64.2% of HER2‐negative BC were HER2‐low BC, and the stratified proportions of HER2‐low BC were 61.9% and 75.2% for HR‐positive and HR‐negative BC, respectively. Compared to HER2‐zero BC, HER2‐low BC among HR‐positive BC showed younger age at diagnosis, later stage, poorer differentiation, and higher Ki‐67, while elder age at diagnosis and lower mortality were observed for HER2‐low BC among HR‐negative BC (all p values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesGenetic Predisposition to DiseaseAdultAgedFemaleHumansMiddle AgedAsian PeopleCase-Control StudiesChinaPolymorphism, Single NucleotidePrognosis

Stichwörter der Autor:innen

HER2-low BCHER2-zero BCSNPsbreast cancerpolygenic risk scoreprognosis

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Tianjin's Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Me…
  • Department of Infectious Disease Control and Prevention, Heping Centers for Disease Control and Prevention of Tianjin, Tianjin, China.
  • Department of Breast Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

ORCID-Profile: Fengju Song

Förderung

  • Chinese National Key Research and Development Project
  • National Natural Science Foundation of China
  • Tianjin Health Committee Foundation
  • Tianjin Science and Technology Committee Foundation

Zitieren

APA

Zheng, L., Zhang, Y., Wang, Z., Wang, H., Hao, C., Li, C., Zhao, Y., Lyu, Z., Song, F., Chen, K., Huang, Y., & Song, F. (2023). Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2 ‐low and HER2 ‐zero breast cancer among Chinese females. Cancer Medicine. https://doi.org/10.1002/cam4.6129

Vancouver

Zheng L, Zhang Y, Wang Z, Wang H, Hao C, Li C, et al. Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2 ‐low and HER2 ‐zero breast cancer among Chinese females. Cancer Medicine. 2023. doi:10.1002/cam4.6129

BibTeX
@article{Zheng2023,
  author = {Zheng, Lu and Zhang, Yunmeng and Wang, Zhipeng and Wang, Huan and Hao, Chunfang and Li, Chenyang and Zhao, Yanrui and Lyu, Zhangyan and Song, Fangfang and Chen, Kexin and Huang, Yubei and Song, Fengju},
  title = {Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2 ‐low and HER2 ‐zero breast cancer among Chinese females},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6129}
}
Kostenlos starten →